DaVita
DVA
#2023
Rank
NZ$16.86 B
Marketcap
NZ$255.68
Share price
0.16%
Change (1 day)
8.68%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.32

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$17.22. In 2024 the company made an earnings per share (EPS) of NZ$18.76 an increase over its 2023 EPS that were of NZ$12.95.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.32-7.68%
2024NZ$18.7644.94%
2023NZ$12.9527.26%
2022NZ$10.17-35.56%
2021NZ$15.7944.1%
2020NZ$10.9619.7%
2019NZ$9.15540.48%
2018NZ$1.43-76.07%
2017NZ$5.97-19.31%
2016NZ$7.40242.52%
2015NZ$2.16-62.87%
2014NZ$5.8213.43%
2013NZ$5.138.45%
2012NZ$4.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$39.93 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.91 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$25.01 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.23-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA